approved EB-2 (NIW)

Postdoctoral Fellow

Pharmacy · Bangladesh · 2021-11-22

Processing Time
238 days
Decision Date
2021-11-22
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing effective aerosol formulations using in vivo studies to confirm optimal aerosol stability. This work aims to provide improved treatments for lung disease by addressing critical issues in respiratory drug delivery and formulation development.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical issues related to lung disease treatment in the United States and globally.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 14 years of experience, a significant publication record, and 202 citations demonstrating leadership in the field.

3 Waiver of Job Offer and Labor Certification Met

Based on the petitioner's expertise and the importance of the work, it was found beneficial to the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on 26 peer-reviewed journal articles and 5 conference articles, with a total of 202 citations. The petitioner also demonstrated expertise through 31 peer-review invitations and 14 years of research experience, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Software Engineer

Artificial Intelligence · India

WeGreened EB-2 (NIW) approved
California 111 days 2026-12-13
The petitioner proposes to develop AI-driven activity monitoring methods for quality assurance in large-scale digital systems. The work focuses on identifying risks earlier and improving reliability to reduce costly disruptions across complex software platforms.

Management Consultant

Information Technology

WeGreened EB-2 (NIW) approved
2026-03-15
The petitioner proposes to continue their work in enterprise technology transformation, governance, and large-scale operational strategy. The work focuses on enhancing enterprise resilience, cybersecurity alignment, and digital transformation within major organizations to improve high-stakes operational settings.

Researcher

Healthcare

WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.

Others

Information Technology · China

WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-11-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 238 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist